Drug diversion is the illegal trafficking and use of legitimately made controlled substances, such as controlled pharmaceuticals. It can lead to opioid misuse and abuse.
The survey polled 651 hospital executives, diversion managers, anesthesiologists, pharmacists, pharmacy technicians and nurses between Feb. 20 and Feb. 28.
Four findings:
1. Eighty-five percent of respondents said they recognized drug diversion as a problem at U.S hospitals, and around 50 percent said they have observed suspicious activity in their hospitals that could have been evidence of diversion.
2. Only 20 percent, however, said they believe drug diversion is a cause for concern at the facilities where they work.
3. Fifty-nine percent of executives want more accurate data to reduce false positives, while 54 percent want artificial intelligence or machine learning technologies and advanced analytics to identify drug diversion.
4. Fifty-three percent of executives said they would support mandatory diversion training.
More articles on opioids:
KLAS: Prescription intelligence software helps improve opioid prescribing practices
Majority of cancer surgery patients discharged without opioids with new pain management protocol, study finds
Georgia officials partner with Appriss Health to integrate PDMP into EHRs
